269 related articles for article (PubMed ID: 28659221)
1. QTc interval in patients with schizophrenia receiving antipsychotic treatment as monotherapy or polypharmacy.
Elliott A; Mørk TJ; Højlund M; Christensen T; Jeppesen R; Madsen N; Viuff AG; Hjorth P; Nielsen JC; Munk-Jørgensen P
CNS Spectr; 2018 Aug; 23(4):278-283. PubMed ID: 28659221
[TBL] [Abstract][Full Text] [Related]
2. Schizophrenia, antipsychotic drugs, and cardiovascular disease.
Glassman AH
J Clin Psychiatry; 2005; 66 Suppl 6():5-10. PubMed ID: 16107178
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval.
Barbui C; Bighelli I; Carrà G; Castellazzi M; Lucii C; Martinotti G; Nosè M; Ostuzzi G;
PLoS One; 2016; 11(2):e0148212. PubMed ID: 26840602
[TBL] [Abstract][Full Text] [Related]
4. Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics.
Yang FD; Wang XQ; Liu XP; Zhao KX; Fu WH; Hao XR; Zhang XL; Huang GS; Qu SC; Bai JS; Huang XF; Kosten TR; Zhang XY
Psychopharmacology (Berl); 2011 Jul; 216(1):9-16. PubMed ID: 21301815
[TBL] [Abstract][Full Text] [Related]
5. QTc interval in a sample of long-term schizophrenia inpatients.
Ramos-Ríos R; Arrojo-Romero M; Paz-Silva E; Carballal-Calvo F; Bouzón-Barreiro JL; Seoane-Prado J; Codesido-Barcala R; Crespí-Armenteros A; Fernández-Pérez R; López-Moríñigo JD; Tortajada-Bonaselt I; Diaz FJ; de Leon J
Schizophr Res; 2010 Jan; 116(1):35-43. PubMed ID: 19892525
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review.
Takeuchi H; Suzuki T; Remington G; Uchida H
Can J Psychiatry; 2015 May; 60(5):215-22. PubMed ID: 26174525
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
Haddad PM; Anderson IM
Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
[TBL] [Abstract][Full Text] [Related]
8. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
[TBL] [Abstract][Full Text] [Related]
9. QTc interval measurement and metabolic parameters in psychiatric patients taking typical or atypical antipsychotic drugs: a preliminary study.
Mackin P; Young AH
J Clin Psychiatry; 2005 Nov; 66(11):1386-91. PubMed ID: 16420075
[TBL] [Abstract][Full Text] [Related]
10. The QTc interval and its dispersion in patients receiving two atypical antipsychotics.
Correll CU; Frederickson AM; Figen V; Ginn-Scott EJ; Pantaleon Moya RA; Kane JM; Manu P
Eur Arch Psychiatry Clin Neurosci; 2009 Feb; 259(1):23-7. PubMed ID: 18574608
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.
Glassman AH; Bigger JT
Am J Psychiatry; 2001 Nov; 158(11):1774-82. PubMed ID: 11691681
[TBL] [Abstract][Full Text] [Related]
12. Ziprasidone in the management of schizophrenia : the QT interval issue in context.
Taylor D
CNS Drugs; 2003; 17(6):423-30. PubMed ID: 12697001
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study.
Nosè M; Bighelli I; Castellazzi M; Martinotti G; Carrà G; Lucii C; Ostuzzi G; Sozzi F; Barbui C;
Epidemiol Psychiatr Sci; 2016 Dec; 25(6):532-540. PubMed ID: 26467074
[TBL] [Abstract][Full Text] [Related]
14. A Real-World Study of Risk Factors for QTc Prolongation in Schizophrenia Patients Receiving Atypical Antipsychotics.
He L; Yu Y; Zhang L; He S; Yu W; Li L; Huang J; Li H
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):71-74. PubMed ID: 34928562
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of antipsychotics and QTc prolongation: a pilot study.
Høimark L; Uhrskov Sørensen L; Vukelic Andersen L
Nord J Psychiatry; 2020; 74(5):374-379. PubMed ID: 32105154
[No Abstract] [Full Text] [Related]
16. Mechanisms and risks of electrocardiographic QT interval prolongation when using antipsychotic drugs.
Vieweg WV
J Clin Psychiatry; 2002; 63 Suppl 9():18-24. PubMed ID: 12088172
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.
Czekalla J; Beasley CM; Dellva MA; Berg PH; Grundy S
J Clin Psychiatry; 2001 Mar; 62(3):191-8. PubMed ID: 11305706
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic drugs and QT interval prolongation.
Zareba W; Lin DA
Psychiatr Q; 2003; 74(3):291-306. PubMed ID: 12918603
[TBL] [Abstract][Full Text] [Related]
19. QTc interval lengthening in first-episode schizophrenia (FES) patients in the earliest stages of antipsychotic treatment.
Zhai D; Lang Y; Dong G; Liu Y; Wang X; Zhou D; Cui T; Yang Y; Zhang W; Zhao Y; Zhang R
Schizophr Res; 2017 Jan; 179():70-74. PubMed ID: 27727006
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study.
Correll CU; Harris J; Figen V; Kane JM; Manu P
J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):365-8. PubMed ID: 21823910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
